1. Home
  2. NCSM vs CLGN Comparison

NCSM vs CLGN Comparison

Compare NCSM & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCSM
  • CLGN
  • Stock Information
  • Founded
  • NCSM 2006
  • CLGN 2004
  • Country
  • NCSM United States
  • CLGN Israel
  • Employees
  • NCSM N/A
  • CLGN N/A
  • Industry
  • NCSM Oilfield Services/Equipment
  • CLGN Industrial Specialties
  • Sector
  • NCSM Energy
  • CLGN Health Care
  • Exchange
  • NCSM Nasdaq
  • CLGN Nasdaq
  • Market Cap
  • NCSM 51.9M
  • CLGN 44.1M
  • IPO Year
  • NCSM 2017
  • CLGN N/A
  • Fundamental
  • Price
  • NCSM $23.73
  • CLGN $4.17
  • Analyst Decision
  • NCSM
  • CLGN Strong Buy
  • Analyst Count
  • NCSM 0
  • CLGN 2
  • Target Price
  • NCSM N/A
  • CLGN $12.50
  • AVG Volume (30 Days)
  • NCSM 5.4K
  • CLGN 17.9K
  • Earning Date
  • NCSM 10-30-2024
  • CLGN 11-27-2024
  • Dividend Yield
  • NCSM N/A
  • CLGN N/A
  • EPS Growth
  • NCSM N/A
  • CLGN N/A
  • EPS
  • NCSM 16.77
  • CLGN N/A
  • Revenue
  • NCSM $152,801,000.00
  • CLGN $689,000.00
  • Revenue This Year
  • NCSM $13.26
  • CLGN N/A
  • Revenue Next Year
  • NCSM $6.32
  • CLGN $670.03
  • P/E Ratio
  • NCSM $1.42
  • CLGN N/A
  • Revenue Growth
  • NCSM 3.66
  • CLGN N/A
  • 52 Week Low
  • NCSM $12.16
  • CLGN $3.61
  • 52 Week High
  • NCSM $24.95
  • CLGN $6.99
  • Technical
  • Relative Strength Index (RSI)
  • NCSM 69.32
  • CLGN 50.20
  • Support Level
  • NCSM $22.21
  • CLGN $3.97
  • Resistance Level
  • NCSM $24.75
  • CLGN $4.41
  • Average True Range (ATR)
  • NCSM 0.86
  • CLGN 0.26
  • MACD
  • NCSM 0.21
  • CLGN 0.06
  • Stochastic Oscillator
  • NCSM 78.87
  • CLGN 57.22

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: